Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1993)
All Articles published online
|
Apr 15, 2001 (publication date) through May 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fan ZR, Yang DH, Cui J, Qin HR, Huang CC. Expression of insulin like growth factor II and its receptor in hepatocellular carcinogenesis. World J Gastroenterol 2001; 7(2): 285-288 [PMID: 11819776 DOI: 10.3748/wjg.v7.i2.285] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i2/285.htm |
| Number | Citing Articles |
| 1 |
Fidel D. Huitzil‐Melendez, Ghassan K. Abou‐Alfa, Michael A. Morse. Malignant Liver Tumors. 2010; : 382 doi: 10.1002/9781444317053.ch32
|
| 2 |
Neung Hwa Park, Il Han Song, Young-Hwa Chung. Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma. Gut and Liver 2007; 1(2): 101 doi: 10.5009/gnl.2007.1.2.101
|
| 3 |
Roberta Pang, Eric Tse, Ronnie T.P. Poon. Molecular pathways in hepatocellular carcinoma. Cancer Letters 2006; 240(2): 157 doi: 10.1016/j.canlet.2005.08.031
|
| 4 |
Zheng Wang, You-Bing Ruan, Yang Guan, Sheng-Hong Liu. Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis. World Journal of Gastroenterology 2003; 9(2): 267-270 doi: 10.3748/wjg.v9.i2.267
|
| 5 |
Lian-Jun Yang, Wen-Liang Wang. Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization. World Journal of Gastroenterology 2002; 8(5): 808-814 doi: 10.3748/wjg.v8.i5.808
|
| 6 |
Xuan Wang, Fu-Kun Liu, Xi Li, Jai-Sou Li, Gen-Xin Xu. Inhibitory effect of endostatin expressed by human liver carcinoma SMMC7721 on endothelial cell proliferation <italic>in vitro</italic>. World Journal of Gastroenterology 2002; 8(2): 253-257 doi: 10.3748/wjg.v8.i2.253
|
| 7 |
C. Morace, M. Cucunato, R. Bellerone, G. De Caro, S. Crinò, A. Fortiguerra, F. Spadaro, A. Zirilli, A. Alibrandi, P. Consolo, C. Luigiano, M.L. Resta, O. Ferraù, A. Spadaro. Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma?. European Journal of Internal Medicine 2012; 23(6): e157 doi: 10.1016/j.ejim.2012.04.014
|
| 8 |
Yun-Lin Wu, Jing Ye, Shu Zhang, Jie Zhong, Rong-Ping Xi. Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis. World Journal of Gastroenterology 2004; 10(18): 2740-2743 doi: 10.3748/wjg.v10.i18.2740
|
| 9 |
Yuanyuan Ji, Zhidong Wang, Zongfang Li, Na Huang, Haiyan Chen, Baohua Li, Bo Hui. Silencing IGF-II impairs C-myc and N-ras expressions of SMMC-7721 cells via suppressing FAK/PI3K/Akt signaling pathway. Cytokine 2017; 90: 44 doi: 10.1016/j.cyto.2016.10.008
|
| 10 |
Lun-Xiu Qin, Zhao-You Tang, Zeng-Chen Ma, Zhi-Quan Wu, Xin-Da Zhou, Qing-Hai Ye, Yuan Ji, Li-Wen Huang, Hu-Liang Jia, Hui-Chuan Sun, Lu Wang. p53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection. World Journal of Gastroenterology 2002; 8(3): 459-463 doi: 10.3748/wjg.v8.i3.459
|
| 11 |
Xi Li, Geng-Feng Fu, Yan-Rong Fan, Chan-Fu Shi, Xin-Juan Liu, Gen-Xing Xu, Jian-Jun Wang. Potent inhibition of angiogenesis and liver tumor growth by administration of an aerosol containing a transferrin-liposome-endostatin complex. World Journal of Gastroenterology 2003; 9(2): 262-266 doi: 10.3748/wjg.v9.i2.262
|
| 12 |
Miao-Wang Hao, Ying-Rui Liang, Yan-Fang Liu, Li Liu, Ming-Yao Wu, Huan-Xing Yang. Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines. World Journal of Gastroenterology 2002; 8(2): 203-207 doi: 10.3748/wjg.v8.i2.203
|
| 13 |
Kai Breuhahn, Peter Schirmacher. Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(11): 1690-1698 doi: 10.3748/wjg.14.1690
|
| 14 |
Nearmeen M. Rashad, Amal S. El-Shal, Eman H. Abd Elbary, Mohamed H. Abo Warda, Osama Hegazy. Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinoma. Cytokine 2014; 68(1): 50 doi: 10.1016/j.cyto.2014.02.006
|
| 15 |
N H Park, I H Song, Y-H Chung. Chronic hepatitis B in hepatocarcinogenesis. Postgraduate Medical Journal 2006; 82(970): 507 doi: 10.1136/pgmj.2006.047431
|
| 16 |
Zhao-Shan Niu, Bo-Kian Li, Mei Wang. Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues. World Journal of Gastroenterology 2002; 8(5): 822-826 doi: 10.3748/wjg.v8.i5.822
|
| 17 |
Zheng-Xu Wang, Gui-Fang Hu, Hong-Yang Wang, Meng-Chao Wu. Expression of liver cancer associated gene HCCA3. World Journal of Gastroenterology 2001; 7(6): 821-825 doi: 10.3748/wjg.v7.i6.821
|
| 18 |
Zhao-Cai Yu, Jie Ding, Bo-Rong Pan, Dai-Ming Fan, Xue-Yong Zhang. Expression and bioactivity identification of soluble MG<sub>7</sub> scFv. World Journal of Gastroenterology 2002; 8(1): 99-102 doi: 10.3748/wjg.v8.i1.99
|